Pharmafile Logo
Pharmafocus logo
Advanced Search

drugs

Showing 15 posts of 771 posts found.

suboxone

Indivior rocked by loss of patent case

March 23, 2018
Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical

Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of …

News
cancer-389921_960_720

Lifestyle factors to blame for 38% of cancers

March 23, 2018
Medical Communications Cancer, Cancer Research UK, UK government, biotech, drugs, pharma, pharmaceutical

A new study by Cancer Research UK has found that more than 135,500 cases of cancer every year in the …

News
gsk_boronia_australia

GSK withdraws from running for Pfizer Consumer Health

March 23, 2018
Medical Communications, Sales and Marketing GSK, Pfizer, Pfizer Consumer Health, biotech, drugs, pharma, pharmaceutical

GSK has announced that it has decided to pull out of the race to acquire Pfizer’s Consumer Health business, ending …

News
handshake

Regeneron-Alnylam team up to treat NASH

March 22, 2018
Research and Development, Sales and Marketing Alnylam, Regeneron, biotech, drugs, nash, pharma, pharmaceutical

Coming on the back of a Regeneron research piece published in the New England Journal of Medicine, the company announced …

News
bayer_cross_2

Bayer-Monsanto deal one step closer, after EU nod

March 22, 2018
Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical

The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …

News
sun_pharma

Sun Pharma receives approval for first biologic drug

March 22, 2018
Sales and Marketing Sun Pharma, biotech, drugs, pharma, pharmaceutical

The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as …

News
brexit_flag_0

Independent committee report seeks Brexit healthcare clarity

March 21, 2018
Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical

An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …

News
dominic_caruso

J&J’s longest-standing CFO finally steps down

March 21, 2018
Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical

Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from …

News
celgene_1_02

Celgene bucks trend to strengthen neuroscience pipeline

March 21, 2018
Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …

News
sandoz_3

Novartis steps into the medical marijuana business

March 20, 2018
Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical

Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …

News
rocheroof

Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer

March 20, 2018
Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …

News
upper-body-944557_960_720

Vertex “astonished” by NHS England’s response to CF drug

March 20, 2018
Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Vertex has been battling to have its treatment, Orkambi, approved in the UK since 2016, when it was first rejected …

News
sperium-2505952_960_720

Male contraceptive pill hits safety goals

March 19, 2018
Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical

A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …

News

Lundbeck takes risk on Parkinson’s treatment, €905m on table

March 19, 2018
Sales and Marketing Lundbeck, Parkinson's, biotech, drugs, pharma, pharmaceutical

CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …

News

Pfizer to hang onto CEO, after 61% pay increase

March 19, 2018
Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025